Open access
97
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results
Martine Hoogendoorn1 institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, the Netherlands, [email protected]Correspondence[email protected]
, Isaac Corro Ramos1 institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, the Netherlands, [email protected]
, Michael Baldwin2 Boehringer Ingelheim GmbH, Ingelheim, Germany
, Laura Luciani3 Boehringer Ingelheim France, Paris, France
, Cecile Fabron4 Cemka-Eval, Bourg-la-Reine, France
, Bruno Detournay4 Cemka-Eval, Bourg-la-Reine, France
& Maureen P M H Rutten-van Mölken1 institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, the Netherlands, [email protected];5 Erasmus School of Health Policy & Management (ESHPM), Erasmus University Rotterdam, Rotterdam, the Netherlands
show all
Pages 447-456
|
Published online: 18 Feb 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.